• Ayse Cirakoglu, Rahiye Dilhan Kuru, Sukriye Yilmaz, Ayhan Deviren, Seniz Ongoren, Fevzi Firat Yalniz, Dilek Keskin, Ahmet Emre Eskazan, Ayse Salihoglu, Cem ArMuhlisMIstanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Internal Medicine, Division of Hematology., Serdar Sahin, Yildiz Aydin, Seniha Hacihanefioglu, Zafer Baslar, Teoman Soysal, and Yelda Tarkan Arguden.
• Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Medical Biology.
• Afr Health Sci. 2022 Sep 1; 22 (3): 183191183-191.

BackgroundCytogenetic findings are important prognostic factors in acute myeloid leukemia. Large systematic data about chromosomal characteristics of Turkish AML patients have not been reported to date.ObjectivesThe karyotypic profiles of 157 adult AML patients were evaluated retrospectively and compared with other reports from different populations.MethodsCytogenetics analyses were performed on bone marrow samples using G-banding. Patients were categorized according to their cytogenetic results into four groups with the addition of a normal karyotyped group to the favorable, intermediate and adverse groups of European Leukemia Network.ResultsCytogenetic analyses were carried out successfully in 138 patients (88%). Abnormal karyotypes were found in 79 (57.2%) patients of which 13 (9.4%) were in favorable, 37 (26.8%) in intermediate and 29 (21%) in adverse groups. t(8;21) (5%) was the most common favorable abnormality while monosomal karyotypes (15.9%) in adverse group.ConclusionThis single center study is the most comprehensive study about the cytogenetic profile of acute myeloid leukemia in Turkey with comparison of other population-based studies. While there were similarities and differences with different publications, our results did not show a marked tendency to the findings of any specific geographic region.© 2022 Cirakoglu A et al.

13 keywords...

hide…